Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Camurus CAMX Apr 25, 2025 589.00 +0.17   
 Candles Scandinavia CANDLEB Apr 25, 2025 16.60 +0.91   
 Cantargia CANTA Apr 25, 2025 1.63 +4.49   
 Carasent CARA Apr 25, 2025 23.91 +4.62   
 Carbiotix CRBX Apr 25, 2025 9.60 -5.88   
 Cardeon CARDEO Apr 25, 2025 0.10 0.00   
 Careium AB CARE Apr 25, 2025 28.10 0.00   
 Case CASE Apr 25, 2025 15.00 -1.32   
 Castellum CAST Apr 25, 2025 115.70 -0.73   
 Catella A CATA Apr 25, 2025 26.20 0.00   
 Catella B CATB Apr 25, 2025 29.54 +0.08   
 Catena CATE Apr 25, 2025 448.80 +0.54   
 Catena Media CTM Apr 25, 2025 2.06 -1.44   
 Cavendish Hydrogen CAVENO Apr 25, 2025 6.47 +21.85   
 Cavotec SA CCC Apr 25, 2025 15.50 -1.59   
 CDON CDON Apr 25, 2025 50.40 +1.82   
 Cedergrenska CEDER Apr 25, 2025 32.00 +0.63   
 Cell Impact CI Apr 25, 2025 0.08 +5.75   
 CellaVision CEVI Apr 25, 2025 162.40 -1.58   
 Cereno Scientific B CRNOB Apr 25, 2025 8.00 +0.38   
 ChargePanel AB (publ) CHARGE Apr 25, 2025 1.21 +1.68   
 Checkin.com Group CHECK Apr 25, 2025 9.12 -1.94   
 Cheffelo CHEF Apr 25, 2025 45.75 +7.19   
 Chordate Medical Holding CMH Apr 25, 2025 5.80 +4.69   
 Chordate Medical Holding Pref CMHPREF Apr 25, 2025 2.85 0.00   
 Chosa Oncology AB CHOSA Apr 25, 2025 0.79 +3.95   
 Cibus Nordic Real Estate CIBUS Apr 25, 2025 162.00 +0.78   
 Cinclus Pharma Holding AB CINPHA Apr 25, 2025 10.40 -0.19   
 Cinis Fertilizer AB CINIS Apr 25, 2025 2.00 -0.74   
 Cint Group CINT Apr 25, 2025 7.23 -7.78   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.